Royalty Pharma PLC (RPRX) Stock Price, Quote, News & History

RPRXNASDAQ
$61.41
0.560.92%
At close: Aug 28, 5:00 PM EST
$61.56
0.711.17%
Pre-Market: 3:00 AM EST
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
2.98B
Investing Cash Flow (TTM)
-2.51B
Financing Cash Flow (TTM)
-282.68M
Free Cash Flow (TTM)
2.98B
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
180.08M

Analyst Trends and Forecast

2
Apr
2
May
1
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$34.58B
PE Ratio (TTM)
33.02
PE Ratio (FWD)
47.62
PEG Ratio (TTM)
2.17
PS Ratio (TTM)
13.51
PB Ratio (TTM)
4.00
Earnings Yield % (TTM)
3.03%
Earnings Yield % (FWD)
2.10%
EV / EBITDA (TTM)
20.19
Price / EBITDA (TTM)
20.01
Price / Free Cash Flow (TTM)
11.51
Book Value / Share
$15.34

Company Debt

Total Debt
$8.96B
LT Debt
$8.58B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$811.99M
Debt to Equity
1.31
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$61.41
Volume / Avg.
0 / 3.37M
Day Range
- - -
52 Wk Range
34.08 - 62.46
Market Cap
$27.41B
P/E Ratio
33.02
Dividend Yield
1.53%
Exchange
NASDAQ
RSI
63
Short Interest
2.64%
Days to Cover
3.77

About

Sector
Health Care
Industry
Pharmaceuticals
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Royalty Pharma (RPRX) stock?

A

You can purchase shares of Royalty Pharma (NASDAQ:RPRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Royalty Pharma (RPRX) competitors?

Q

What is the forecast, or price target, for Royalty Pharma (RPRX) stock?

A

Royalty Pharma has a consensus price target of $53.78.

Q

What is the current price for Royalty Pharma (RPRX)?

A

The stock price for Royalty Pharma (NASDAQ: RPRX) is $61.56 last updated August 31, 2026 at 6:48 PM EDT.

Q

Does Royalty Pharma (RPRX) pay a dividend?

A

There are no upcoming dividends for Royalty Pharma.

Q

When is Royalty Pharma (NASDAQ:RPRX) reporting earnings?

A

Royalty Pharma does not have any upcoming earnings scheduled.

Q

Is Royalty Pharma (RPRX) going to split?

A

There is no upcoming split for Royalty Pharma.

Q

What sector and industry does Royalty Pharma (RPRX) operate in?

A

Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.